Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C23H26N2O3.C4H4O4 |
| Molecular Weight | 494.5363 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)\C=C/C(O)=O.COC1=CC=C(C=C1)C(=O)C2=C(C)N(CCN3CCOCC3)C4=C2C=CC=C4
InChI
InChIKey=DOYGKOLTUWPTGK-BTJKTKAUSA-N
InChI=1S/C23H26N2O3.C4H4O4/c1-17-22(23(26)18-7-9-19(27-2)10-8-18)20-5-3-4-6-21(20)25(17)12-11-24-13-15-28-16-14-24;5-3(6)1-2-4(7)8/h3-10H,11-16H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-
| Molecular Formula | C23H26N2O3 |
| Molecular Weight | 378.4641 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C4H4O4 |
| Molecular Weight | 116.0722 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Pravadoline is the anti-nociceptive agent, which has analgesic efficacy against postoperative pain in humans. Pravadoline inhibits the enzyme cyclooxygenase, but in contrast to cyclooxygenase-inhibiting NSAIDs does not produce gastrointestinal irritation. Pravadoline inhibited the synthesis of prostaglandins in mouse brain both in vitro and ex vivo. Pravadoline demonstrated only weak anti-inflammatory activity relative to its anti-nociceptive potency. Single doses of pravadoline were safe and effective in humans, without serious adverse events. Single oral administration of pravadoline maleate induced acute tubular necrosis in male and female beagle dogs.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0001516 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2243340 |
4.9 µM [IC50] | ||
| 2511.0 nM [Ki] | |||
Target ID: CHEMBL2111349 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2243340 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cells. | 2014-02 |
|
| Effects of the cannabinoid CB1 receptor antagonist rimonabant on distinct measures of impulsive behavior in rats. | 2007-07 |
|
| Aminoalkylindoles: structure-activity relationships of novel cannabinoid mimetics. | 1995-08-04 |
|
| Nephrotoxicity of pravadoline maleate (WIN 48098-6) in dogs: evidence of maleic acid-induced acute tubular necrosis. | 1993-07 |
|
| Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids. | 1993-03 |
|
| Pravadoline: profile in isolated tissue preparations. | 1990-12 |
|
| Pharmacology of pravadoline: a new analgesic agent. | 1990-11 |
|
| Pravadoline and aminoalkylindole (AAI) analogues: actions which suggest a receptor interaction. | 1989-12 |
Sample Use Guides
200, 400 or 800 mg single dose
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2175798
Pravadoline (10 and 100 uM) reduced PGE2 content in guinea pig ileum (P < .05).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:45:01 GMT 2025
by
admin
on
Mon Mar 31 17:45:01 GMT 2025
|
| Record UNII |
2DH4X8278M
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1323
Created by
admin on Mon Mar 31 17:45:01 GMT 2025 , Edited by admin on Mon Mar 31 17:45:01 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
92623-84-2
Created by
admin on Mon Mar 31 17:45:01 GMT 2025 , Edited by admin on Mon Mar 31 17:45:01 GMT 2025
|
PRIMARY | |||
|
CHEMBL13178
Created by
admin on Mon Mar 31 17:45:01 GMT 2025 , Edited by admin on Mon Mar 31 17:45:01 GMT 2025
|
PRIMARY | |||
|
9957393
Created by
admin on Mon Mar 31 17:45:01 GMT 2025 , Edited by admin on Mon Mar 31 17:45:01 GMT 2025
|
PRIMARY | |||
|
300000055012
Created by
admin on Mon Mar 31 17:45:01 GMT 2025 , Edited by admin on Mon Mar 31 17:45:01 GMT 2025
|
PRIMARY | |||
|
C062767
Created by
admin on Mon Mar 31 17:45:01 GMT 2025 , Edited by admin on Mon Mar 31 17:45:01 GMT 2025
|
PRIMARY | |||
|
2DH4X8278M
Created by
admin on Mon Mar 31 17:45:01 GMT 2025 , Edited by admin on Mon Mar 31 17:45:01 GMT 2025
|
PRIMARY | |||
|
Y-95
Created by
admin on Mon Mar 31 17:45:01 GMT 2025 , Edited by admin on Mon Mar 31 17:45:01 GMT 2025
|
PRIMARY | |||
|
C81065
Created by
admin on Mon Mar 31 17:45:01 GMT 2025 , Edited by admin on Mon Mar 31 17:45:01 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |